Signals, Powered By EquityPandit
Aurobindo Pharma has got the USFDA final approval for manufacturing and marketing the generic version of heartburn relief medicine Famotidine tablets.
The company has said in a BSE filing that the approval by the US Food and Drug Administration (USFDA) is for strengths of 10 mg and 20 mg.
It further said that this product is expected to be launched in the second quarter of 2016-17.
Aurobindo Pharma has also got the USFDA final approval for manufacturing and marketing the pain relief drug Oxymorphone Hydrochloride tablets in the strengths of 5 mg and 10 mg.
It further said that “The approved ANDA is bio-equivalent and therapeutically equivalent to the reference listed drug product Opana (Oxymorphone Hydrochloride) tablets, 5 mg and 10 mg, of Endo Pharmaceuticals, Inc.”
